ID   520C9
AC   CVCL_G612
SY   520C9.C3B10T; 520 C9
DR   CLO; CLO_0001408
DR   ATCC; HB-8696
DR   Wikidata; Q54603715
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US5169774;
RX   PubMed=1715033;
RX   PubMed=2470501;
WW   https://casetext.com/case/chiron-corporation-v-genentech-inc-edcal-2002?__cf_chl_jschl_tk__
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8696.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
RX   Patent=US4753894;
RA   Frankel A.E., Ring D.B., Bjorn M.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US4753894, 28-Jun-1988.
//
RX   Patent=US4938948;
RA   Ring D.B., Frankel A.E.;
RT   "Method for imaging breast tumors using labeled monoclonal anti-human
RT   breast cancer antibodies.";
RL   Patent number US4938948, 03-Jul-1990.
//
RX   Patent=US5169774;
RA   Frankel A.E., Ring D.B., Laird W.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US5169774, 08-Dec-1992.
//
RX   PubMed=1715033; DOI=10.1016/0161-5890(91)90056-p;
RA   Ring D.B., Clark R., Saxena A.;
RT   "Identity of BCA200 and c-erbB-2 indicated by reactivity of monoclonal
RT   antibodies with recombinant c-erbB-2.";
RL   Mol. Immunol. 28:915-917(1991).
//
RX   PubMed=2470501;
RA   Ring D.B., Kassel J.A., Hsieh-Ma S.T., Bjorn M.J., Tringale F.,
RA   Eaton A.M., Reid S.A., Frankel A.E., Nadji M.;
RT   "Distribution and physical properties of BCA200, a Mr 200,000
RT   glycoprotein selectively associated with human breast cancer.";
RL   Cancer Res. 49:3070-3080(1989).
//